Search for Clinical Trial Results

Sponsored By

Myopia, Degenerative - 15 Studies Found

Status Study
Recruiting Study Name: Genomewide Screening of Pathological Myopia
Condition: Pathological Myopia
Date: 2005-09-09
Recruiting Study Name: Early Vitrectomy for Macular Tractional Maculopathy
Condition: Myopia, Degenerative
Date: 2010-04-30
Interventions: Procedure: Early vitrectomy Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine gree
Completed Study Name: Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia
Condition: Myopia, Degenerative
Date: 2013-07-10
Interventions:
  • Drug: PDT standard fluence, ranibizumab

Completed Study Name: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
Condition:
  • Choroidal Neovascularization
  • Myopia, Degenerative

Date: 2011-08-22
Interventions: Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/-
Completed Study Name: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen
Condition: Choroidal Neovascularisation
Date: 2009-12-21
Interventions: Drug: ranibizumab 0.5mg
Completed Study Name: Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Condition: Pathological Myopia
Date: 2010-10-06
Interventions:
  • Drug: Ranibizumab 0.5 mg ranib
Completed Study Name: A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV
Condition: Choroid Neovascularization Secondary to Degenerative Myopia
Date: 2013-03-11
Interventions:
  • Drug: conbercept, Fixed intrav
Completed Study Name: Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
Condition:
  • Choroidal Neovascularization
  • Degenerative Myopia
  • Date: 2006-12-01
    Interventions: Drug: Bevacizumab
Recruiting Study Name: Ocular Discomfort Assessment After Intravitreal Injections
Condition:
  • Macular Degeneration
  • Diabetic Retinopathy
  • Retinal Artery O
    Date: 2016-06-14
    Interventions: Drug: Optive Optive eye drops will be prescribed to each included patients after their second intravitre
Recruiting Study Name: Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
Condition: